Company news
Cryosite Limited (ASX:CTE) news
Every Cryosite Limited press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Appendix 4E and 2026 Annual Report
August 18, 2026
Trading Update - Full Year Results - 30 June 2026
July 12, 2026
Trading Update - Financial Year-to-Date - 30 April 2026
May 26, 2026
Appendix 4D and Half Year Accounts
February 26, 2026
Trading Update - Q1 FY26
October 12, 2025
Acquisition of Strategic Warehouse Facility
October 1, 2025
Appendix 4E and 2025 Annual Report
August 21, 2025
Chairman's Update and Board and Management Change
August 20, 2024
Appendix 4E and 2024 Annual Report
August 20, 2024
Chairman's Update, Board Change and Corporate Presentation
May 8, 2024
Corporate Presentation
May 8, 2024
Proposed Equal Reduction of Capital
January 4, 2024
Appendix 4E and 2023 Annual Report
August 24, 2023
Appendix 4D and Half Year Report
February 23, 2023
2022 AGM - Chairmans Address to Shareholders
November 16, 2022
Appendix 4E and Annual Report
August 25, 2022
Chairmans Address to Shareholders
December 7, 2021
Changes relating to buy-back - Appendix 3D
May 14, 2021
Early Closure of On Market Buy Back
May 3, 2021
Announcement of buy-back - Appendix 3C
March 10, 2021
Appointment of CEO
October 15, 2020
Appendix 4E and Annual Report to Shareholders
August 27, 2020
Response to ASX Price Query
May 28, 2020
Appendix 4d and Half Year accounts
February 27, 2020
Cryosite to receive $1M in settlement of legal claim
August 27, 2019
Trading update and staff restructure
June 27, 2019
Federal Court approves in principle settlement
February 13, 2019
Cryosite reaches in principle settlement with ACCC
February 8, 2019
Appendix4E and Annual report
August 29, 2018
Trading Update
August 1, 2018
ACCC proceedings
July 12, 2018
Cell Care transaction not to proceed. Meeting Cancelled
January 8, 2018
ACCC ends review of Cell Care's Cryosite assets acquisition
December 20, 2017
Trading update
November 21, 2017
ACCC update
November 7, 2017
Cryosite : Confirmation of Release - CTE - Appendix 4E and Annual Report - 23 August 2017
August 23, 2017
Cryosite : Confirmation of Release - CTE - Appendix 4G and Corporate Governance Statement - 23 August 2017
August 23, 2017
ACCC review of proposed transaction of Cord Blood assets
August 3, 2017
Cryosite : Form 604 substantial shareholder notice 3 JULY 2017
July 3, 2017
Cryosite to license its CB&T brand and sell certain assets
June 23, 2017
Cryosite : CTE - Appointment of Interim CEO 23-JUNE-2017
June 22, 2017
Appointment of Interim CEO
June 14, 2017
Resignation of CEO
May 19, 2017
Cryosite : CEO package 08-MAR-2017
March 7, 2017
Cryosite : CTE CLAWBACK POLICY - 2 March 2017
March 2, 2017
Cryosite : Appendix 3a dividend 28-FEB-2017
February 28, 2017
Cryosite : App4D and signed half year accounts December 2016 23-FEB-2017
February 23, 2017
Cryosite : CTE Personnel Share Trading Policy clean version 7-FEB-2017
February 7, 2017
Cryosite : CTE - Nomination and Remuneration Committee Charter 7-FEB-2017
February 7, 2017
Cryosite : CTE- Audit and Risk Committee Charter 7-FEB-2017
February 7, 2017